Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000017283-02-000662
Filing Date
2002-04-08
Accepted
2002-04-08 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G edgamln.txt SC 13G 6966
  Complete submission text file 0000017283-02-000662.txt   8965
Mailing Address 333 SOUTH HOPE STREET 55TH FL LOS ANGELES CA 90071
Business Address 333 SOUTH HOPE ST 55TH FLOOR LOS ANGELES CA 90071 2134869200
CAPITAL RESEARCH & MANAGEMENT CO (Filed by) CIK: 0000017283 (see all company filings)

EIN.: 951411037 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 0000

Mailing Address 9373 TOWNE CENTRE DR SAN DIEGO CA 92121
Business Address 9373 TOWNE CENTRE DR SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Subject) CIK: 0000881464 (see all company filings)

EIN.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42168 | Film No.: 02604940
SIC: 2834 Pharmaceutical Preparations